Product Information
PAXIL CR 12.5 MG TABLET is a brand product labeled by Apotex Corp., priced at $9.7181 per EA under NDC 60505437703. Its NADAC has been published 155 times since Dec 25, 2019.
The High Outlier badge above means this manufacturer's average price in the paroxetine hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Apotex Corp.NDC
60505437703
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
PAROXETINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020936On Market Since
1/1/2011
Pharmacological Classes
Price Statistics
The NADAC for PAXIL CR 12.5 MG TABLET has been published 155 times since Dec 25, 2019, and over the history we have for it it has risen 49.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.7181 per EA |
|---|---|
| All-time high | $9.7567 (Aug 13, 2025) |
| All-time low | $6.4991 (Dec 25, 2019) |
| 52-week high | $9.7567 |
| 52-week low | $9.6558 |
| Median price | $7.0840 |
| Average price | $8.1685 |
| Largest weekly change | +24.1% (Apr 17, 2024) |
| Weeks tracked | 155 |
| Tracking since | Dec 25, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 95% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAXIL CR 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAXIL CR 12.5 MG TABLET, manufactured by Apotex Corp., is $9.7181 per EA (NDC 60505437703), effective Oct 1, 2025.
How has the price of PAXIL CR 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAXIL CR 12.5 MG TABLET has risen 49.5%. It has been tracked across 155 weekly CMS publications since Dec 25, 2019.
What are the highest and lowest recorded NADAC prices for PAXIL CR 12.5 MG TABLET?
Since Dec 25, 2019, the NADAC for PAXIL CR 12.5 MG TABLET has ranged from a low of $6.4991 (Dec 25, 2019) to a high of $9.7567 (Aug 13, 2025), with a median of $7.0840 per EA.
Are there cheaper alternatives to PAXIL CR 12.5 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, PAROXETINE CR 12.5 MG TABLET, is $0.4929 per EA — about 95% below PAXIL CR 12.5 MG TABLET.
Who manufactures PAXIL CR 12.5 MG TABLET?
PAXIL CR 12.5 MG TABLET (NDC 60505437703) is labeled by Apotex Corp., and CMS classifies it as a brand product.
Related Drugs
Same classification